ImmunityBio Provides Update on BLA for N-803
ImmunityBio (IBRX) continues to explore partnering with a large biopharmaceutical co for commercialization of N-803 for administration intravesically. continues to engage in ongoing...
Neutral
or
NantKwest Inc News & Analysis
-
-
N.Korea says Thursday’s launch was Hwasong-17 ICBM -NK News
SEOUL (Reuters) – North Korea said that Thursday’s launch was an Hwasong-17 ICBM (intercontinental ballistic missile), with leader Kim Jong Un watching with his daughter, NK News said,...
-
Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR Meeting
SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a biotechnology company innovating next-generation cell and gene...
-
Affimed Announces Presentations of Clinical Data from AFM13 Phase 2 REDIRECT and Pre-clinical Data Demonstrating CD16A Shedding Facilitates Repetitive Targeting of Tumor Cells by AFM13-armed NK Cells at the Annual Meeting of the American Association for C
An oral presentation on the safety and efficacy from the AFM13 phase 2 monotherapy clinical study ("REDIRECT") in patients with CD30-positive relapsed or refractory (R/R) peripheral T-cell...
-
NantKwest Inc earnings missed by $0.05, revenue topped estimates
Investing.com - NantKwest Inc (NASDAQ: IBRX) reported first quarter EPS of $-0.27, $0.05 worse than the analyst estimate of $-0.22. Revenue for the quarter came in at $73.00K versus the...
-
ImmunityBio Executes $50M Equity Financing with Multiple Institutional Investors
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it has executed financing to provide further working capital and support its ongoing business...
-
NantKwest Inc Earnings miss, Revenue beats In Q3
Investing.com - NantKwest Inc reported on Friday third quarter {{erl-958237||earnings that missed analysts' forecasts and revenue that topped expectations. NantKwest Inc announced earnings...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.08%
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Financials, Technology and Consumer Services sectors propelled shares higher while losses in the Utilities,...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.29%
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Basic Materials, Technology and Consumer Goods sectors propelled shares higher. At the close in NYSE, the...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.06%
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Consumer Goods, Consumer Services and Industrials sectors propelled shares higher while losses in the...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.11%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Utilities, Technology and Basic Materials sectors propelled shares higher while losses in the Industrials,...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
